Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2000
09/13/2000EP1034270A1 Compositions and methods of use of het
09/13/2000EP1034269A1 An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
09/13/2000EP1034268A1 G-protein coupled receptors and uses therefor
09/13/2000EP1034267A1 Compositions and methods for inducing gene expression
09/13/2000EP1034266A1 Method for preparing adenovirus vectors, vectors so prepared, and uses thereof
09/13/2000EP1034265A1 Human cdc10 homolog
09/13/2000EP1034264A1 Splice variants for human 5-ht 4? serotonin receptor and their applications, in particular for screening
09/13/2000EP1034263A1 The nip3 family of proteins
09/13/2000EP1034262A1 Compositions and methods for genetic modification of plants
09/13/2000EP1034261A2 Method of parallel screening for insertion mutants and a kit to perform this method
09/13/2000EP1034260A2 Novel dna cloning method relying on the e. coli rece/rect recombination system
09/13/2000EP1034259A1 Cloning method by multiple digestion, vectors for implementing same and applications
09/13/2000EP1034258A2 Nucleic acid transfer vector for the introduction of nucleic acid into the dna of a cell
09/13/2000EP1034257A2 Yac vectors
09/13/2000EP1034252A2 Attenuated strains of mycobacteria
09/13/2000EP1034221A1 Dibenzorhodamine dyes useful as fluorescent labelling agents
09/13/2000EP1034187A1 $i(IN VITRO) AND $i(IN VIVO) GROWTH-PROMOTING PROTEINS AND PEPTIDES FOR KIDNEY EPITHELIAL CELLS
09/13/2000EP1034185A2 Pharmaceutical compositions containing the long pentraxin ptx3
09/13/2000EP1034004A1 Recombinant mycoplasma hyopneumoniae vaccine
09/13/2000EP1034000A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
09/13/2000EP1033996A1 Prevention and treatment of amyloidogenic disease
09/13/2000EP1033992A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections
09/13/2000EP1007649A4 Methods to screen for transcription factor-coactivator interactions
09/13/2000EP0938557B1 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit
09/13/2000EP0832207B1 A method for identification of biologically active peptides and nucleic acids
09/13/2000EP0826066B1 Methods and reagents for combined pcr amplification and hybridization probing assay
09/13/2000EP0814834B1 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies directed against said immunogens, preparation method therefor, and pharmaceutical compositions containing the same
09/13/2000EP0772624B1 Interleukin-15
09/13/2000EP0733059B1 Compounds and methods for site-directed mutations in eukaryotic cells
09/13/2000EP0571500B1 A high sulfur seed protein gene and method for increasing the sulfur amino acid content of plants
09/13/2000EP0514488B1 Retinoid receptor compositions and methods
09/13/2000EP0183776B2 A process for isolating and activating a substantially insoluble polypeptide using non-ionic detergents.
09/13/2000CN1266538A Retentate chromatography and protein chip arrays applications in biology and medicine
09/13/2000CN1266537A Retentate chromatography and protein chip arrays with applications in biology and medicine
09/13/2000CN1266460A Diacrylglycerol acyl transferase proteins
09/13/2000CN1266459A Method and reagents for vaccination which generate a CD8 T cell immune response
09/13/2000CN1266458A Novel DNA fragments ordering gene expression predominant in flower organ
09/13/2000CN1266457A Mold-resistant plants and method of construction of same
09/13/2000CN1266456A Kinase activating dependent cyclin protein kinases, and their uses
09/13/2000CN1266101A Astaxanthin synthetic enzyme
09/13/2000CN1266100A Chemical synthesis, expression and recombinant protein production for human serum albumin reformed gene
09/13/2000CN1266099A Chemical synthesis, expression and recombinant protein production for human serum albumin reformed gene (I)
09/13/2000CN1266098A Growth mark regulated by growth hormone
09/13/2000CN1266097A Process for preparing recombinant natookinase
09/13/2000CN1265921A Erythropoiesis for treating anemia of family and raised animals
09/13/2000CN1056407C Live bacteria preparation containing Bacillus subtilis and its application in treatment of burns
09/13/2000CN1056382C Improved HCV diagnostic agents
09/13/2000CA2381124A1 Cloning pigs using donor cells or nuclei from differentiated cells and production of pluripotent porcine
09/12/2000US6118053 Inbred maize line PH0JG
09/12/2000US6118050 Nucleic acid which encodes polypeptide of defined amino acid sequence; transgenic cells and seeds; for screening herbicides
09/12/2000US6118049 Synthetic hybrid tomato E4/E8 plant promoter
09/12/2000US6118048 Trans-dominant inhibition of geminiviral DNA replication by geminivirus rep gene mutants
09/12/2000US6118047 Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction
09/12/2000US6118045 Mammal having transgene with promoter and enhancer from same mammary gland specific gene, signal sequence for mammary secretory cells, and recombinant dna coding for acid alpha glucosidase; processed/secreted enzyme for pompe's disease
09/12/2000US6118044 Transgenic animal allergy models and methods for their use
09/12/2000US6117991 Plasmid pav2-htsh-beta on deposit as atcc 75505; for recombinant production, diagnosis and therapy of human thyroid cancer; anticarcinogenic agents
09/12/2000US6117990 Recombinant nucleic acid encoding a human g protein coupled receptor having a defined amino acid sequence; antiarthritic agents; anticarcinogenic/antidiabetic/antiepileptic agents; hypotensive/hypertensive agents; diagnosis of diseases
09/12/2000US6117989 Human calcium-binding proteins
09/12/2000US6117983 Methods for purifying authentic IGF from yeast hosts
09/12/2000US6117981 Hybridomas for lung cancer marker and monoclonal antibodies thereof
09/12/2000US6117978 Protein having at least 63% identity to human protein having defined amino acid sequence; for diagnosis and therapy of alzheimer's disease; drug screening
09/12/2000US6117975 Amino acid and nucleotide sequences; for therapy
09/12/2000US6117848 Antisense oligonucleotide inhibition of ras
09/12/2000US6117847 For use in inhibiting the function of nucleic acid molecules encoding protein kinase c (pkc), ultimately modulating the amount of pkc produced; for treating cancer, inflammation, psoriasis
09/12/2000US6117839 For increasing bone growth in mammals
09/12/2000US6117681 Pseudotyped retroviral particles
09/12/2000US6117680 Compositions and methods for regulation of transcription
09/12/2000US6117679 Adjusting polynucleotide sequences; amplifying nucleotide sequences and screening a recombinant polynucleotide for a desired property
09/12/2000US6117677 Plant stearoyl-ACP desaturases genes
09/12/2000US6117676 Transfected human amniotic cells and method for producing a gene product
09/12/2000US6117673 Nucleotide sequence which codes for a protein associated signal tranduction; for diagnosis, treatment and preventing defects associated with signal transduction
09/12/2000US6117670 Pyrrolnitrin biosynthesis genes and uses thereof
09/12/2000US6117669 Nucleotide sequence coding an enzymatic polypeptide
09/12/2000US6117665 DNA molecules coding for debranching enzymes derived from plants
09/12/2000US6117662 Respiratory nitrate reductase alpha subunit
09/12/2000US6117661 Mutant mono-oxygenase cytochrome P450cam
09/12/2000US6117659 Recombinant narbonolide polyketide synthase
09/12/2000US6117658 Methods of making polyhydroxyalkanoates comprising 4-hydroxybutyrate monomer units
09/12/2000US6117657 Enzymatic nucleic acid molecule containing one or more non-nucleotide mimetics, and having activity to cleave an rna or dna molecule
09/12/2000US6117655 Nucleic acid encoding adhesion variants
09/12/2000US6117654 Nucleotide sequence coding antiinflammatroy proteins; antiarthritic agents; antiinflammatory agents; bronchodilator agents
09/12/2000US6117653 Hepatitis B surface antigen vaccine
09/12/2000US6117651 Genetically engineered nucleic acid sequences linked to bacterial promoter and code heterologous polypeptides; for expressing a desired polypeptide in bacterial cells at high levels
09/12/2000US6117649 Genetically engineered yeast strains
09/12/2000US6117645 Human LH-RH receptor expression cells and use thereof
09/12/2000US6117641 Assays and reagents for identifying anti-fungal agents and uses related thereto
09/12/2000US6117639 Screening for enzyme inhibitors against proteases, determining inhibitory activity; novel transcriptional assay using DNA molecules encoding the fusion protein substrates; Hepatitis C Virus NS3 protease or HIV aspartyl protease
09/12/2000US6117638 Detection of test compounds that modulate gene expression by triggering activation; incubation of nucleic acids with a activator and test compound, detecting expression of reporter gene products, adjustment in expression indicates modulation
09/12/2000US6117636 Screening for the presence fungi and yeast in a sample; amplifying nucleotide sequences using preferential primers and polymerase chain reaction, detecting amplification products
09/12/2000US6117635 Nucleotide sequence with fluorescein or derivative attached to 5' terminal and 4(4'-dimethylaminophenylazo)benzoic acid attached to nucleotide 22; for ?closed tube? format which decreases possibility of carryover contamination
09/12/2000US6117633 Detecting nucleotide sequences coding antitumor protein; hyridizing sequences of normal and cancer cells, probing libraries with sequences, isolating and fragmenting clones, insertion in vectors, isolate specific nucleotide sequences
09/12/2000US6117426 Human amine transporter polypeptide fragments
09/12/2000US6117422 Genetic engineering
09/12/2000US6117421 Method for promoting cell growth and immunosuppression using chaperonin
09/12/2000US6117398 System for releasing and isolating nucleic acids
09/12/2000CA2158024C A mycoplasma gallisepticum antigen, dna encoding the antigen, recombinant vector bearing the dna and recombinant virus utilizing the recombinant vector as well as use thereof
09/12/2000CA2087610C Biologically safe plant transformation system
09/12/2000CA2087105C Non-corrosive composition and methods useful for the extraction of nucleic acids
09/12/2000CA2051375C Process and compositions for the isolation of human relaxin
09/12/2000CA2021762C Antigens and methods therefor